Black Creek Investment Management Inc. Grifols Sa Transaction History

Black Creek Investment Management Inc.

$3.3 Billion
Q1 2024

A detailed history of Black Creek Investment Management Inc. transactions in Grifols Sa stock. As of the latest transaction made, Black Creek Investment Management Inc. holds 11,458,159 shares of GRFS stock, worth $72.2 Million. This represents 2.32% of its overall portfolio holdings.

Number of Shares

11,458,159

Previous 9,251,618 23.85%

Holding current value

$72.2 Million

Previous $107 Million 28.43%

% of portfolio

2.32%

Previous 3.52%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$5.47 - $11.38 $12.1 Million - $25.1 Million	2,206,541 Added 23.85%	11,458,159 $76.5 Million
Q4 2023 Feb 13, 2024	SELL	$7.71 - $11.56 $2.49 Million - $3.73 Million	-322,770 Reduced 3.37%	9,251,618 $107 Million
Q3 2023 Nov 13, 2023	BUY	$8.91 - $10.91 $12 Million - $14.7 Million	1,351,000 Added 16.43%	9,574,388 $87.5 Million
Q2 2023 Aug 10, 2023	BUY	$7.14 - $9.29 $5.01 Million - $6.51 Million	701,008 Added 9.32%	8,223,388 $75.3 Million
Q1 2023 May 09, 2023	BUY	$6.65 - $10.69 $3.98 Million - $6.39 Million	597,905 Added 8.63%	7,522,380 $55.4 Million

Q4 2022 Feb 14, 2023	BUY	$5.96 - $8.53 $36,594 - $52,374	6,140 Added 0.09%	6,924,475 $58.9 Million
Q3 2022 Nov 09, 2022	SELL	$5.95 - $14.3 $3,195 - $7,679	-537 Reduced 0.01%	6,918,335 $42.6 Million
Q2 2022 Aug 11, 2022	SELL	$10.6 - $13.28 $1.81 Million - $2.27 Million	-171,000 Reduced 2.41%	6,918,872 $82.2 Million
Q1 2022 May 06, 2022	BUY	$10.37 - $12.73 $11 Million - $13.5 Million	1,064,065 Added 17.66%	7,089,872 $82.8 Million
Q4 2021 Feb 15, 2022	BUY	$10.21 - $15.27 $5.23 Million - $7.83 Million	512,509 Added 9.3%	6,025,807 $67.7 Million
Q3 2021 Nov 05, 2021	BUY	$14.07 - $17.3 $7.46 Million - $9.17 Million	529,928 Added 10.63%	5,513,298 $80.5 Million
Q2 2021 Aug 12, 2021	BUY	$16.62 - $18.94 $3.74 Million - $4.27 Million	225,231 Added 4.73%	4,983,370 $86.5 Million
Q1 2021 May 06, 2021	BUY	$15.15 - $19.78 $16 Million - $20.9 Million	1,058,790 Added 28.62%	4,758,139 $82.3 Million
Q4 2020 Feb 08, 2021	BUY	$16.86 - $19.67 $6.41 Million - $7.48 Million	380,100 Added 11.45%	3,699,349 $68.2 Million
Q3 2020 Nov 09, 2020	SELL	$15.4 - $20.16 $200,200 - $262,080	-13,000 Reduced 0.39%	3,319,249 $57.6 Million
Q2 2020 Aug 11, 2020	BUY	$18.24 - $21.45 $876,942 - $1.03 Million	48,078 Added 1.46%	3,332,249 $60.8 Million
Q1 2020 May 08, 2020	SELL	$16.28 - $25.63 $13.1 Million - $20.7 Million	-807,493 Reduced 19.74%	3,284,171 $66.1 Million
Q4 2019 Feb 11, 2020	BUY	$19.57 - $23.52 $4.2 Million - $5.05 Million	214,729 Added 5.54%	4,091,664 $95.3 Million
Q3 2019 Nov 12, 2019	BUY	$19.85 - $22.76 $3.5 Million - $4.01 Million	176,281 Added 4.76%	3,876,935 $77.7 Million
Q2 2019 Aug 13, 2019	BUY	$17.59 - $21.1 $7.63 Million - $9.15 Million	433,752 Added 13.28%	3,700,654 $78.1 Million
Q1 2019 May 13, 2019	BUY	$18.01 - $20.11 $811,458 - $906,076	45,056 Added 1.4%	3,266,902 $65.7 Million
Q4 2018 Feb 12, 2019	BUY	$17.44 - $21.53 $8.29 Million - $10.2 Million	475,326 Added 17.31%	3,221,846 $59.2 Million
Q3 2018 Nov 09, 2018	BUY	$19.97 - $21.96 $9.54 Million - $10.5 Million	477,571 Added 21.05%	2,746,520 $58.7 Million
Q2 2018 Aug 13, 2018	SELL	$20.16 - $24.68 $711,627 - $871,179	-35,299 Reduced 1.53%	2,268,949 $48.8 Million
Q1 2018 May 11, 2018	SELL	$20.31 - $24.95 $2.92 Million - $3.59 Million	-143,792 Reduced 5.87%	2,304,248 $48.9 Million
Q4 2017 Feb 09, 2018	BUY	$20.99 - $23.89 $5.69 Million - $6.48 Million	271,301 Added 12.46%	2,448,040 $56.1 Million
Q3 2017 Nov 13, 2017	SELL	$20.07 - $21.89 $80,280 - $87,560	-4,000 Reduced 0.18%	2,176,739 $47.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	2,180,739	2,180,739 $46.1 Million

Others Institutions Holding GRFS

# of Institutions

150

Shares Held

140M

Call Options Held

3.54M

Put Options Held

919K

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.28B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Creek Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Creek Investment Management Inc. with notifications on news.

Account

Black Creek Investment Management Inc. Grifols Sa Transaction History